Clopidogrel treatment in a patient with ticlopidine-induced hepatitis following percutaneous coronary stenting

被引：0
|
作者：
Anselmino, M. [1 ]
Moretti, C. [1 ]
Ravera, L. [1 ]
Sheiban, I. [1 ]
机构：
[1] Univ Turin, Div Cardiol, Dept Med, San Giovanni Battista Hosp, I-10126 Turin, Italy
来源：
MINERVA CARDIOANGIOLOGICA | 2010年 / 58卷 / 02期
关键词：
Cerebrovascular disorders; Cardiovascular diseases; Hepatitis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Thienopyridines are commonly prescribed antiplatelets drugs, extremely useful for the acute and chronic management of patients with cerebrovascular and cardiovascular diseases. The occurrence of their side effects is fortunately uncommon, although unpredictable. We thereby describe a case of prescription of clopidogrel in a patient with ticlopidine-induced hepatitis confirmed by liver biopsy that had undergone multiple percutaneous coronary stenting procedures necessitating subsequent compulsory antiplatelets treatment. The description of this exceptional clinical case is of relevant knowledge to orientate a physician treating a patient with absolute need of antiplatelets and history of previous drug-induced reactions.
引用
收藏
页码：277 / 280
页数：4
相关论文
共 50 条
  • [21] Ticlopidine-induced cholestatic hepatitis - Report of three cases and review of the literature
    Iqbal, M
    Goenka, P
    Young, MF
    Thomas, E
    Borthwick, TR
    DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (10) : 2223 - 2226
  • [22] Ticlopidine-induced cholestatic hepatitis successfully treated with corticosteroids: a case report
    Leone, N
    Giordanino, C
    Baronio, MB
    Morgando, A
    David, E
    Rizzetto, M
    HEPATOLOGY RESEARCH, 2004, 28 (02) : 109 - 112
  • [23] Ticlopidine-induced cholestatic hepatitis with anti-nuclear antibody in serum
    Tsai, MH
    Tsai, SL
    Chen, TC
    Liaw, YF
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2000, 99 (11) : 866 - 869
  • [24] The impact of genetic factors on susceptibility to the development of ticlopidine-induced cholestatic hepatitis
    Kraslova, I
    Muchova, L
    Vitek, L
    Novotny, A
    Svestka, T
    Bruha, R
    JOURNAL OF HEPATOLOGY, 2005, 42 : 249 - 249
  • [25] A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stenting
    Müller, C
    Büttner, HJ
    Petersen, J
    Roskamm, H
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 4A - 4A
  • [26] Rash with both clopidogrel and ticlopidine in two patients following percutaneous coronary intervention with drug-eluting stents
    Makkar, Kathy
    Wilensky, Robert L.
    Julien, Maureen Burke
    Herrmann, Howard C.
    Spinler, Sarah A.
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (06) : 1204 - 1207
  • [27] TICLOPIDINE AND SUBCUTANEOUS HEPARIN AS AN ALTERNATIVE REGIMEN FOLLOWING CORONARY STENTING
    BARRAGAN, P
    SAINSOUS, J
    SILVESTRI, M
    BOUVIER, JL
    COMET, B
    SIMEONI, JB
    CHARMASSON, C
    BREMONDY, M
    CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1994, 32 (02): : 133 - 138
  • [28] Case Report: Ticlopidine-Induced Cholestatic Hepatitis Report of Three Cases and Review of the Literature
    Muhammed Iqbal
    Puneet Goenka
    Mark F. Young
    Eapen Thomas
    Thomas R. Borthwick
    Digestive Diseases and Sciences, 1998, 43 : 2223 - 2226
  • [29] Clopidogrel discontinuation and platelet reactivity following coronary stenting
    Mylotte, D.
    Peace, A. J.
    Tedesco, A. T.
    Mangiacapra, F.
    Dicker, P.
    Kenny, D.
    Foley, D. P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (01) : 24 - 32
  • [30] Ticlopidine-induced severe agranulocytosis after the placement of coronary artery stent - A case report
    Sari, R
    Sevinc, A
    Buyukberber, S
    ANGIOLOGY, 2000, 51 (07) : 591 - 593
12345